Skip to main content

Advertisement

ADVERTISEMENT

Department

Formulary Frontlines®
03/17/2017
The health care landscape is shifting from a fee-for-service to a pay-for-performance model.
The health care landscape is shifting from a fee-for-service to a pay-for-performance model.
The health care landscape is...
03/17/2017
First Report Managed Care

Advertisement

Formulary Frontlines®
03/06/2017
Richard G Soper, MD, JD, MS, discusses the financial impact on payers from prescription opioid abuse and offers cost reduction strategies.
Richard G Soper, MD, JD, MS, discusses the financial impact on payers from prescription opioid abuse and offers cost reduction strategies.
Richard G Soper, MD, JD,...
03/06/2017
First Report Managed Care
Managed Care Q&A
03/03/2017
Rami Doukky, MD, MSc, speaks about the development of appropriate use criteria for cardiac imaging and the implementation of laws mandating their use.
Rami Doukky, MD, MSc, speaks about the development of appropriate use criteria for cardiac imaging and the implementation of laws mandating their use.
Rami Doukky, MD, MSc,...
03/03/2017
First Report Managed Care
Managed Care Q&A
02/15/2017
Jim Polsfut, CEO of the North American Specialty Hospital recently said, "The bottom line for employers: even after factoring in the cost of travel and accommodations for the patient… the savings are significant."
Jim Polsfut, CEO of the North American Specialty Hospital recently said, "The bottom line for employers: even after factoring in the cost of travel and accommodations for the patient… the savings are significant."
Jim Polsfut, CEO of the North...
02/15/2017
First Report Managed Care

Advertisement

News Connection
02/15/2017
Last month, the FDA released its guidance for drugmakers attempting to gain approval for interchangeability between a biosimilar and reference product. 
Last month, the FDA released its guidance for drugmakers attempting to gain approval for interchangeability between a biosimilar and reference product. 
Last month, the FDA released its...
02/15/2017
First Report Managed Care
News Connection
02/15/2017
California assemblyman Jim Wood, DDS, introduced legislation that would prohibit the use of prescription drug coupons for medications with cheaper alternatives.
California assemblyman Jim Wood, DDS, introduced legislation that would prohibit the use of prescription drug coupons for medications with cheaper alternatives.
California assemblyman Jim Wood,...
02/15/2017
First Report Managed Care
News Connection
02/15/2017
The US Senate officially confirmed Representative Tom Price, MD, to head the Department of Health and Human Services, with a 52-48 vote.
The US Senate officially confirmed Representative Tom Price, MD, to head the Department of Health and Human Services, with a 52-48 vote.
The US Senate officially...
02/15/2017
First Report Managed Care

Advertisement

News Connection
02/15/2017
Results from a recent trial showed that Repatha reduces the risk of cardiovascular events in patients with clinically evident atherosclerotic cardiovascular disease.
Results from a recent trial showed that Repatha reduces the risk of cardiovascular events in patients with clinically evident atherosclerotic cardiovascular disease.
Results from a recent trial...
02/15/2017
First Report Managed Care
News Connection
02/15/2017
The FDA, under accelerated approval, has approved intravenous Opdivo (nivolumab, Bristol-Myers Squibb) for patients with locally advanced or metastatic urothelial carcinoma whose disease has progressed during or following platinum-containing...
The FDA, under accelerated approval, has approved intravenous Opdivo (nivolumab, Bristol-Myers Squibb) for patients with locally advanced or metastatic urothelial carcinoma whose disease has progressed during or following platinum-containing...
The FDA, under accelerated...
02/15/2017
First Report Managed Care
News Connection
02/15/2017
Used as monotherapy, ertugliflozin provides effective glycemic control for patients with type 2 diabetes inadequately treated by diet and exercise alone. 
Used as monotherapy, ertugliflozin provides effective glycemic control for patients with type 2 diabetes inadequately treated by diet and exercise alone. 
Used as monotherapy,...
02/15/2017
First Report Managed Care

Advertisement

Advertisement